Stellar Biotechnologies Inc. (SBOTF)

[1sq1]

I was going to comment on one of the Directors of Stellar.
That would be Dr. Daniel E. Morse Ph.D. Received his Masters at Harvard in Microbiology, and then his Ph.D at Albert Einstein College of Medicine. Then I reviewed the rest of the Directors. they include no less that 5 Ph.D's, in disciplines from microbiology to pharmacology. These Doctors can work anywhere they want. Obviously, they feel they are contributing to humanity with their work at Stellar Biotechnologies. This company is for real and is vastly undervalued. The .10 - .20 gains we've seen really don't reflect what we have here. The only source of sustainable KLH, a unique protein that carries targeted immunity therapies. We will look back at these prices and wonder why we just didn't get it before big Pharma buys it up.